GSK Says Chronic Hepatitis B Treatment Approved in Japan

MT newswire2026/08/24 08:06

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

04:06 AM EDT, 08/24/2026 (MT Newswires) -- GSK (GSK) announced on Monday that Japan's Ministry of Health, Labor and Welfare has approved the company's drug Hibsago, or bepirovirsen, as a functional cure for chronic hepatitis B virus infection in certain patients. Adult patients who have received at least six months of prior nucleoside/nucleotide analogue therapy and who meet pre-defined viral markers are eligible to receive Hibsago. This is the first global approval for Hibsago, and the first and only functional cure treatment for chronic hepatitis B approved in Japan, reported GSK, in a filing with the London Stock Exchange. Chronic hepatitis B affects nearly one million people in Japan with nationwide efforts underway for screening and treatment, said GSK. GSK said it continues to advance regulatory submissions for Hibsago in multiple nations, with decisions, including the US, expected in the coming months.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

According to reports, the trading firm JonesTrading is marketing up to $500 million worth of stock shares on behalf of some investors, at a 3% to 5% premium over the IPO issue price. This indicates that investors are already transferring their anticipated IPO allotted shares before the IPO is officially issued.

华尔街见闻•2026/11/10 23:03

Nvidia continues to plummet, losing $430 billion in market value over two days, with Microsoft temporarily reclaiming the world's second place.

On Tuesday, Nvidia closed down 5.5%, a decline significantly greater than other major tech stocks, making it a key factor dragging down the tech sector's performance. During intraday trading on Tuesday, Microsoft's market capitalization briefly surpassed Nvidia, making it the world's second largest publicly traded company by market value. However, after Anthropic released its office suite, Microsoft's losses widened, causing it to fall behind Nvidia once again.

华尔街见闻•2026/11/10 23:01